Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 2,007 |
| Last Trade Date Time: | 03/03/2026 09:30:25 am |
| Market Cap: | $3,213 |
|---|---|
| Float: | 32,132,907 |
| Insiders Ownership: | 0.02% |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | http://www.rebus-corp.com |
| Country: | US |
| City: | Westlake Village |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Rebus Hldgs Inc (OTCMKTS: RBSH).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
